Bulletin de Périodique
International Journal of Drug Policy , Vol.62 - December 2018
Paru le :
01/12/2018
Article en page(s) :
1-112
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- A mapping review of evaluations of alcohol policy restrictions targeting alcohol-related harm in night-time entertainment precincts. Taylor N., Miller P., Coomber K., Mayshak R., Zahnow R., Patafio B., et al., p. 1-13.
- Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study. Cunningham E.B., Amin J., Feld J.J., Bruneau J., Dalgard O., Powis J., et al., p. 14-23.
- Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits. Folch C., Lorente N., Majo X., Parés-Badell O., Roca X., Brugal T., et al., p. 24-29.
- Quantifying the societal cost of methamphetamine use to Australia. Tait R.J., Whetton S., Shanahan M., Cartwright K., Ferrante A., Gray D., et al., p. 30-36.
- A qualitative study of methamphetamine initiation among Chinese male users: Patterns and policy implications. Liu L., Chui W.H., Chai X., p. 37-42.
- Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan. Davis A., McCrimmon T., Dasgupta A., Gilbert L., Terlikbayeva A., Hunt T., et al., p. 43-50.
- Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities. Zlotorzynska M., Weidle P.J., Paz-Bailey G., Broz D., p. 51-58.
- Drug checking as a potential strategic overdose response in the fentanyl era. Laing M.K., Tupper K.W., Fairbairn N., p. 59-66.
- Perspectives on supervised injection facilities among service industry employees in New York City: A qualitative exploration. Wolfson-Stofko B., Elliott L., Bennett A.S., Curtis R., Gwadz M., p. 67-73.
- Direct-acting antiviral therapy for hepatitis C infection among people receiving opioid agonist treatment or heroin assisted treatment. Scherz N., Bruggmann P., Brunner N., p. 74-77.
- Generating sustainable collective action: Models of community control and governance of alcohol supply in Indigenous minority populations. Shanthosh J., Angell B., Wilson A., Latimer J., Hackett M.L., Eades A.-M., et al., p. 78-85.
- Action-focused, plain language communication for overdose prevention: A qualitative analysis of Rhode Island's overdose surveillance and information dashboard. Waye K.M., Yedinak J.L., Koziol J., Marshall B.D.L., p. 86-93.
- Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy. Grebely J., Conway B., Cunningham E.B., Fraser C., Moriggia A., Gane E., et al., p. 94-103.
- Direct acting antiviral-based treatment of hepatitis C virus infection among people who inject drugs in Georgia: A prospective cohort study. Bouscaillou J., Kikvidze T., Butsashvili M., Labartkava K., Inaridze I., Etienne A., et al., p. 104-111.
- A mapping review of evaluations of alcohol policy restrictions targeting alcohol-related harm in night-time entertainment precincts. Taylor N., Miller P., Coomber K., Mayshak R., Zahnow R., Patafio B., et al., p. 1-13.
- Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study. Cunningham E.B., Amin J., Feld J.J., Bruneau J., Dalgard O., Powis J., et al., p. 14-23.
- Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits. Folch C., Lorente N., Majo X., Parés-Badell O., Roca X., Brugal T., et al., p. 24-29.
- Quantifying the societal cost of methamphetamine use to Australia. Tait R.J., Whetton S., Shanahan M., Cartwright K., Ferrante A., Gray D., et al., p. 30-36.
- A qualitative study of methamphetamine initiation among Chinese male users: Patterns and policy implications. Liu L., Chui W.H., Chai X., p. 37-42.
- Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan. Davis A., McCrimmon T., Dasgupta A., Gilbert L., Terlikbayeva A., Hunt T., et al., p. 43-50.
- Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities. Zlotorzynska M., Weidle P.J., Paz-Bailey G., Broz D., p. 51-58.
- Drug checking as a potential strategic overdose response in the fentanyl era. Laing M.K., Tupper K.W., Fairbairn N., p. 59-66.
- Perspectives on supervised injection facilities among service industry employees in New York City: A qualitative exploration. Wolfson-Stofko B., Elliott L., Bennett A.S., Curtis R., Gwadz M., p. 67-73.
- Direct-acting antiviral therapy for hepatitis C infection among people receiving opioid agonist treatment or heroin assisted treatment. Scherz N., Bruggmann P., Brunner N., p. 74-77.
- Generating sustainable collective action: Models of community control and governance of alcohol supply in Indigenous minority populations. Shanthosh J., Angell B., Wilson A., Latimer J., Hackett M.L., Eades A.-M., et al., p. 78-85.
- Action-focused, plain language communication for overdose prevention: A qualitative analysis of Rhode Island's overdose surveillance and information dashboard. Waye K.M., Yedinak J.L., Koziol J., Marshall B.D.L., p. 86-93.
- Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy. Grebely J., Conway B., Cunningham E.B., Fraser C., Moriggia A., Gane E., et al., p. 94-103.
- Direct acting antiviral-based treatment of hepatitis C virus infection among people who inject drugs in Georgia: A prospective cohort study. Bouscaillou J., Kikvidze T., Butsashvili M., Labartkava K., Inaridze I., Etienne A., et al., p. 104-111.
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
C. FOLCH ;
N. LORENTE ;
X. MAJO ;
O. PARES-BADELL ;
X. ROCA ;
T. BRUGAL ;
P. ROUX ;
P. CARRIERI ;
J. COLOM ;
J. CASABONA ;
REDAN study group
|
2018
Dans International Journal of Drug Policy (Vol.62, December 2018) Article : Périodique
Dans International Journal of Drug Policy (Vol.62, December 2018) Article : Périodique
Background and aims: Despite the availability of several drug consumption rooms (DCR) in different European countries few epidemiological studies have evaluated their benefits. A network of DCR for people who inject drugs (PWID) has existed in C[...]
M. ZLOTORZYNSKA ;
P. J. WEIDLE ;
G. PAZ-BAILEY ;
D. BROZ
|
2018
Dans International Journal of Drug Policy (Vol.62, December 2018) Article : Périodique
Dans International Journal of Drug Policy (Vol.62, December 2018) Article : Périodique
Background: Increased access to sterile syringes has been shown to reduce HIV risk among people who inject drugs (PWID). Where syringe services programs (SSPs) are limited, pharmacies are an important sterile syringe source. We assessed factors [...]
M. K. LAING ;
K. W. TUPPER ;
N. FAIRBAIRN
|
2018
Dans International Journal of Drug Policy (Vol.62, December 2018) Article : Périodique
Dans International Journal of Drug Policy (Vol.62, December 2018) Article : Périodique
Adulteration of illicit drug supplies with synthetic opioids such as fentanyl has contributed to a dramatic rise in overdose morbidity and mortality in North America. One promising response to this crisis is the implementation of "drug checking"[...]
K. M. WAYE ;
J. L. YEDINAK ;
J. KOZIOL ;
B. D. L. MARSHALL
|
2018
Dans International Journal of Drug Policy (Vol.62, December 2018) Article : Périodique
Dans International Journal of Drug Policy (Vol.62, December 2018) Article : Périodique
Background: In 2015, the state of Rhode Island reported the fifth highest drug overdose mortality rate in the United States. In response to this crisis, Rhode Island created a statewide, publicly accessible drug surveillance and information syst[...]